Category: pharmaceutical companies

Lack of Tranparency in Trials for Cancer Medication: Study

A multi-national study led by Australia’s Flinders University has found that more than 50 percent of the clinical trials the U.S. Food and Drugs Administration (FDA) used to approve anti-cancer medications over the past decade are not available for public scrutiny. This comes after the pharmaceutical industry made a commitment in 2014 to improve data transparency….


Team Biden Erodes the IP Protection That Undergirds Global Public Health

Commentary There are ways to do well by doing good, and successful vaccine development is one of them. COVID-19 vaccines are now protecting the world from death and disease. But in the next pandemic—due to the erosion of intellectual property protections for vaccine science on a global level—we may not be so lucky. On June…


Facts Matter (May 12): New NIH Director Admits That $350M Secret Royalty Payments Has Appearance of ‘Conflict of Interest’

The current acting director of the NIH was sitting before Congress on Wednesday, when he admitted that the hundreds of millions of dollars in secret royalty payments, going to men like Dr. Anthony Fauci and Dr. Francis Collins, do have the appearance of a conflict of interest. This comes on the heels of a report…


Vaccine Mandates May Pave Way to Other Coercive Social Policies: Dr. Aaron Kheriaty

Once vaccine mandates are introduced in society and people become accustomed to showing their COVID-19 vaccine certificate to participate in social life, the authorities can use this infrastructure for other coercive policies, according to Dr. Aaron Kheriaty, a former professor of psychiatry and the director of the Medical Ethics Program at the University of California,…